Diane M Janowicz Selected Research

Chancroid

8/2014	A (p)ppGpp-null mutant of Haemophilus ducreyi is partially attenuated in humans due to multiple conflicting phenotypes.
6/2014	Outer membrane protein P4 is not required for virulence in the human challenge model of Haemophilus ducreyi infection.
2/2012	Sialylation of lipooligosaccharides is dispensable for the virulence of Haemophilus ducreyi in humans.
9/2011	Expression of the Flp proteins by Haemophilus ducreyi is necessary for virulence in human volunteers.
5/2006	Expression of Haemophilus ducreyi collagen binding outer membrane protein NcaA is required for virulence in swine and human challenge models of chancroid.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Diane M Janowicz Research Topics

Disease

5	Chancroid 08/2014 - 05/2006
4	Infections 01/2019 - 04/2008
2	Ulcer 01/2019 - 05/2006
2	Sexually Transmitted Diseases (Sexually Transmitted Disease) 06/2014 - 09/2011
1	Abscess 01/2019
1	Bacterial Infections (Bacterial Infection) 01/2019
1	HIV Infections (HIV Infection) 07/2016

Drug/Important Bio-Agent (IBA)

2	RNA (Ribonucleic Acid)IBA 01/2019 - 04/2008
2	Membrane Proteins (Integral Membrane Proteins)IBA 06/2014 - 05/2006
1	Azithromycin (Zithromax)FDA LinkGeneric 01/2019
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2019
1	CarbonIBA 01/2019
1	VaccinesIBA 01/2019
1	Pharmaceutical PreparationsIBA 07/2016
1	Guanosine PentaphosphateIBA 08/2014
1	Lipoproteins (Lipoprotein)IBA 06/2014
1	lipid-linked oligosaccharidesIBA 02/2012
1	Proteins (Proteins, Gene)FDA Link 09/2011
1	CollagenIBA 05/2006

Therapy/Procedure

1	Mass Drug Administration 01/2019